This finding might suggest that either sarcoidosis potentially displays a common immune-mediated background with other CTDs or that the subtypes of ANA-positive sarcoidosis patients might be at higher risk of developing a future overlapping CTD compared with ANA-negative patients [35]. Here, BTG3 is linked to sarcoidosis.